INNOVACAPInnova Captab Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals · CARE: A+ (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 0.2 this quarter.
Momentum from moving averages, Supertrend and RSI.
1 forensic issue found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
1 found · risk minor
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹496 Cr | ₹42 Cr | 11.71% | 8.55% | ₹7.41 | 14.2x |
| Q1 FY2027 | ₹471 Cr | ₹44 Cr | 13.04% | 9.37% | ₹7.71 | 14.3x |
| Q4 FY2026 | ₹448 Cr | ₹38 Cr | 11.99% | 8.50% | ₹6.65 | 12.0x |
| Q3 FY2026 | ₹450 Cr | ₹42 Cr | 12.87% | 9.36% | ₹7.37 | 15.1x |
| Q2 FY2026 | ₹380 Cr | ₹30 Cr | 10.66% | 7.80% | ₹5.18 | 8.1x |
| Q1 FY2026 | ₹352 Cr | ₹31 Cr | 11.68% | 8.82% | ₹5.42 | 15.9x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.